Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
on innovative development and application of novel data-driven methods relying on machine learning, artificial intelligence, or other computational techniques. The specific focus is on development and
-
focus on innovative development and application of novel data-driven methods relying on machine learning, artificial intelligence, or other computational techniques. The applicant is expected to develop
-
grow into real impact. At the division of Data Science and AI , we develop data-driven methods and AI solutions that support intelligent decisions across society, advancing machine learning techniques
-
on development of novel computational methods with state-of-the-art machine learning for gaining fundamental insights into healthy and diseased human tissues of the heart, cardiovascular system, and
-
community of Digital Research Engineers. The offices also host computer infrastructure and machine learning/data science/research data management experts, who develop, build, and manage the local and national
-
++ or similar) and an interest in quantitative or computational approaches are required. Prior experience with image analysis, machine learning, signal processing, or structural biology is meritorious but not
-
biology and genetics. Experience using Git for version control. Ability to quickly learn new skills. Experience working in a Unix/Linux environment. Excellent verbal and written English skills. We
-
-performance computing. SLU provides access to extensive datasets that can be used to develop machine learning methods and automated analyses relevant to the position. Long-term datasets are available from, i.a
-
) training personalized computational models in new contexts, and (iii) studying in-silico clinical intervention strategies. The postdoctoral fellow will have the opportunity to: Learn about computational
-
modeling, machine learning, and AI techniques applied to biomedical data is a plus. Clinical Proteomics: Experience with clinical trial data, real-world evidence (RWE), and biomarker-driven trial designs is